Intubation, EndotrachealNCT00434720
Comparison of GlideScope Specific Stylet to Malleable Stylet for GlideScope Intubation
A study testing GlideScope Specific Stylet in people with Intubation, Endotracheal, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 1 site in Canada.
Trial summary
The GlideScope video laryngoscope (Verathon) is an intubating device that uses a high-resolution camera embedded into a plastic laryngoscope blade. An LED provides illumination. The GlideScope often provides a good laryngoscopic view, but passing the endotracheal tube (ETT) through the vocal cords is sometimes… Read more about this study
- Who is it for?
- Ages 18 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Intubation, Endotracheal
- What is being tested?
- GlideScope Specific Stylet
- Type of treatment
- Medical device
- How many people
- 70 participants
- Where
- 1 siteCanada
- Study dates
- Jan 2007to May 2007
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Any adult patient scheduled for elective surgery.
- ETT is indicated for the procedure in the opinion of the attending anesthesiologist.
- operator who has performed ≥ 10 GlideScope intubations.
Who cannot join
- GlideScope contraindicated in the opinion of the attending anesthesiologist.
- known cervical spine abnormalities.
- known or probable difficult airways.
- rapid sequence induction.
Trial locations and contacts
1 site in 1 country.
About this study
The GlideScope video laryngoscope (Verathon) is an intubating device that uses a high-resolution camera embedded into a plastic laryngoscope blade. An LED provides illumination. The GlideScope often provides a good laryngoscopic view, but passing the endotracheal tube (ETT) through the vocal cords is sometimes difficult. Because of the 60 degree anterior curvature of the GlideScope's blade, ETT's must have stylets inserted so that the ETT distal tip can be positioned anteriorly. Various authors have recommended different angles of the ETT to optimally place it into the trachea. Previous study demonstrated that 90 degree sharp bend was both faster and subjectively easier in a heterogeneous group of intubators. With the introduction of a rigid GlideScope Specific Stylet by the manufacturer, the question arises as to the the best configuration of stylet for the ETT. Therefore, this prospective, randomized, single-blinded trial is proposed.
The null hypothesis is that there will be no difference between the GlideScope Specific Stylet and the standard malleable stylet.
Read the detailed description
Purpose:
To determine the optimum angle of curvature of an endotracheal tube when used with a GlideScope in order to intubate in the most efficient fashion.
Methods:
Groups: A) 90º curvature, malleable stylet B) shallow curvature, rigid GlideScope Specific Stylet
Hypothesis:
The null hypothesis is that there is no difference in the primary outcome (time to intubation). i.e. we hypothesize that the time to intubate is not related to the shape of the endotracheal tube. The control group will be arbitrarily assigned to the 90º group that was the preferred option in a previous trial.
Primary Endpoint:
- Time to intubation (seconds).
Written informed consent will be obtained by one of the study investigators, and a copy will be given to each participant. Written informed consent will also be obtained from the operator of the GlideScope. After consent, randomization will occur by selecting the next consecutive envelope.
There are three distinct anesthesia providers involved in the conduct of this study, as follows:
- "operator" - person performing the intubation
- "timer" - person timing the outcome (one of the co-investigators)
- "shaper" - person who ensures that the angle and stylet of the tube matches the group to which the patient was allocated
Because the person intubating must be blind up until the time at which the tube is to be used, the unopened envelope will be taken to a third anesthesia provider, who will prepare the ETT with stylet in an area that is not visible to the person performing the intubation or to the person timing the intubation. The person performing the intubation will specify what size of tube they wish to use. This will most commonly be 7.5 mm internal diameter (ID) for a female and 8.0 ID for males, but the operator is free to use whatever size they feel is appropriate. The tube size selection will take place before unblinding so the group allocation cannot affect the decision of tube size.
"Group A" ETT's will be shaped with the aid of a standard malleable stylet (Rusch 14 Fr) that has been lubricated with single-use water-soluble lubricant. "Group B" ETT's will be instrumented with the GlideScope Specific Stylet, with identical lubricant. The prepared tube will then be concealed under a standard green OR towel and brought to the operating room (OR). This tube will be placed close to the patient's head so that it is readily accessible.
Data Collection
In the OR, the GlideScope will be turned on at least 60s before use to prevent fogging. The patient will be cared for in the usual fashion with respect to monitoring and induction of general anesthesia. Muscle relaxation will be used, and the agent used is at the discretion of the operator. After induction of anesthesia, bag-mask ventilation will be used in the usual fashion until the operator decides to proceed to laryngoscopy with the GlideScope. The operator will remain blinded to the group allocation until after the laryngoscopic view has been obtained with the GlideScope, where upon he will be handed the endotracheal tube.
The timer (who cannot see the tube under the green towel) will watch the operator until the GlideScope is in the patient's mouth, start the timer, and then turn 180º to face the anesthetic monitor. The timer will not be able to see the ETT, stylet, or curvature because he will be facing the screen.
Timing will continue until end-tidal CO2 of at least 30 mmHg is seen on the anesthesia monitor, at which point the data collection form will be filled out, and the study protocol will be finished. (The time to intubation will be recorded to the nearest tenth of a second.) If the operator fails to intubate within 3 attempts or 150 seconds, the intubation will be noted as a failure, and the ultimately successful means of securing the airway will be recorded.
If oxygen desaturation (as recorded by pulse oximetry) below 95% occurs, then the patient will be ventilated in the usual fashion to ensure oxygenation, and re-attempting intubation using the GlideScope may proceed, but the timing will continue, and the same limits to successful intubation (within 3 attempts or total of 150s) will apply. Between attempts, the tube may be re-shaped by the operator if a malleable stylet is used and either the original curvature has been lost or the operator feels that another curvature would be preferred.
Discontinuation Criteria
If the oxygen saturation falls below 90% occurs at any point, the protocol will stop immediately, and management will proceed in the normal fashion at the discretion of the attending anesthesiologist, which could involve immediate intubation using the GlideScope or other intubation device, or ventilation using a mask or laryngeal mask airway. If, at any time, the attending anesthesiologist believes there is any risk to the patient because of the study protocol, the protocol will be terminated and normal anesthetic care will continue.
- Conditions
- Intubation, Endotracheal
- Being tested
- GlideScope Specific Stylet
- Keywords
- GlideScope, Stylet
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
GlideScope Specific StyletDevice
What is being measured
The primary outcome is the main question the study is designed to answer.
Duration of Intubation
Measured: Timed intubation
Secondary outcomes (1)
Operator Satisfaction
Measured: Post intubation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Feb 2007 (estimated)
- Study startJan 2007
- Primary completionMay 2007
- Study completionMay 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Intubation, EndotrachealStudies of the same condition, open and under way.
- More trials run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Sponsor type
- University, hospital or other
- Investigators
- Timothy P Turkstra, M. Eng, MD, Principal investigator, University of Western Ontario, London Health Sciences Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00434720
- Sponsor's protocol ID
- R-06-490
- Other IDs
- 12754
- Status last verified
- Oct 2008
- First submitted
- 9 Feb 2007
- Last updated
- 16 Oct 2008
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of GlideScope Specific Stylet to Malleable Stylet for GlideScope Intubation
- ClinicalTrials.gov ID
- NCT00434720
- Acronym / sponsor ID
- R-06-490
- Conditions
- Intubation, Endotracheal
- Keywords
- GlideScope, Stylet
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sUniversity, hospital or other
- Study start
- Jan 2007
- Primary completion
- May 2007 (actual)
- Study completion
- May 2007 (actual)
- First posted
- 13 Feb 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The GlideScope video laryngoscope (Verathon) is an intubating device that uses a high-resolution camera embedded into a plastic laryngoscope blade. An LED provides illumination. The GlideScope often provides a good laryngoscopic view, but passing the endotracheal tube (ETT) through the vocal cords is sometimes difficult. Because of the 60 degree anterior curvature of the GlideScope's blade, ETT's must have stylets inserted so that the ETT distal tip can be positioned anteriorly. Various authors have recommended different angles of the ETT to optimally place it into the trachea. Previous study demonstrated that 90 degree sharp bend was both faster and subjectively easier in a heterogeneous group of intubators. With the introduction of a rigid GlideScope Specific Stylet by the manufacturer, the question arises as to the the best configuration of stylet for the ETT. Therefore, this prospective, randomized, single-blinded trial is proposed.
The null hypothesis is that there will be no difference between the GlideScope Specific Stylet and the standard malleable stylet.
Detailed description
Purpose:
To determine the optimum angle of curvature of an endotracheal tube when used with a GlideScope in order to intubate in the most efficient fashion.
Methods:
Groups: A) 90º curvature, malleable stylet B) shallow curvature, rigid GlideScope Specific Stylet
Hypothesis:
The null hypothesis is that there is no difference in the primary outcome (time to intubation). i.e. we hypothesize that the time to intubate is not related to the shape of the endotracheal tube. The control group will be arbitrarily assigned to the 90º group that was the preferred option in a previous trial.
Primary Endpoint:
- Time to intubation (seconds).
Written informed consent will be obtained by one of the study investigators, and a copy will be given to each participant. Written informed consent will also be obtained from the operator of the GlideScope. After consent, randomization will occur by selecting the next consecutive envelope.
There are three distinct anesthesia providers involved in the conduct of this study, as follows:
- "operator" - person performing the intubation
- "timer" - person timing the outcome (one of the co-investigators)
- "shaper" - person who ensures that the angle and stylet of the tube matches the group to which the patient was allocated
Because the person intubating must be blind up until the time at which the tube is to be used, the unopened envelope will be taken to a third anesthesia provider, who will prepare the ETT with stylet in an area that is not visible to the person performing the intubation or to the person timing the intubation. The person performing the intubation will specify what size of tube they wish to use. This will most commonly be 7.5 mm internal diameter (ID) for a female and 8.0 ID for males, but the operator is free to use whatever size they feel is appropriate. The tube size selection will take place before unblinding so the group allocation cannot affect the decision of tube size.
"Group A" ETT's will be shaped with the aid of a standard malleable stylet (Rusch 14 Fr) that has been lubricated with single-use water-soluble lubricant. "Group B" ETT's will be instrumented with the GlideScope Specific Stylet, with identical lubricant. The prepared tube will then be concealed under a standard green OR towel and brought to the operating room (OR). This tube will be placed close to the patient's head so that it is readily accessible.
Data Collection
In the OR, the GlideScope will be turned on at least 60s before use to prevent fogging. The patient will be cared for in the usual fashion with respect to monitoring and induction of general anesthesia. Muscle relaxation will be used, and the agent used is at the discretion of the operator. After induction of anesthesia, bag-mask ventilation will be used in the usual fashion until the operator decides to proceed to laryngoscopy with the GlideScope. The operator will remain blinded to the group allocation until after the laryngoscopic view has been obtained with the GlideScope, where upon he will be handed the endotracheal tube.
The timer (who cannot see the tube under the green towel) will watch the operator until the GlideScope is in the patient's mouth, start the timer, and then turn 180º to face the anesthetic monitor. The timer will not be able to see the ETT, stylet, or curvature because he will be facing the screen.
Timing will continue until end-tidal CO2 of at least 30 mmHg is seen on the anesthesia monitor, at which point the data collection form will be filled out, and the study protocol will be finished. (The time to intubation will be recorded to the nearest tenth of a second.) If the operator fails to intubate within 3 attempts or 150 seconds, the intubation will be noted as a failure, and the ultimately successful means of securing the airway will be recorded.
If oxygen desaturation (as recorded by pulse oximetry) below 95% occurs, then the patient will be ventilated in the usual fashion to ensure oxygenation, and re-attempting intubation using the GlideScope may proceed, but the timing will continue, and the same limits to successful intubation (within 3 attempts or total of 150s) will apply. Between attempts, the tube may be re-shaped by the operator if a malleable stylet is used and either the original curvature has been lost or the operator feels that another curvature would be preferred.
Discontinuation Criteria
If the oxygen saturation falls below 90% occurs at any point, the protocol will stop immediately, and management will proceed in the normal fashion at the discretion of the attending anesthesiologist, which could involve immediate intubation using the GlideScope or other intubation device, or ventilation using a mask or laryngeal mask airway. If, at any time, the attending anesthesiologist believes there is any risk to the patient because of the study protocol, the protocol will be terminated and normal anesthetic care will continue.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Any adult patient scheduled for elective surgery.
- ETT is indicated for the procedure in the opinion of the attending anesthesiologist.
- operator who has performed ≥ 10 GlideScope intubations.
Key exclusion criteria (4 listed)
- GlideScope contraindicated in the opinion of the attending anesthesiologist.
- known cervical spine abnormalities.
- known or probable difficult airways.
- rapid sequence induction.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| GlideScope Specific Stylet | Device | – |
Primary outcome
Duration of Intubation
Time frame: Timed intubation
1 secondary outcome
Operator Satisfaction
Time frame: Post intubation
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2008.
Related trials for Intubation, Endotracheal
Not yet recruitingObservational study
AI-assisted Tracheal Intubation in Children
Intubation
Not yet recruiting
AI Smart Glasses Feedback for Intubation Training in Medical Students
Intubation, Intratracheal, Medical Education
Recruiting
Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use
Critically Ill Patients Requiring Mechanical Ventilation
Recruiting
Effect of a Brief Educational Intervention on Endotracheal Tube Cuff Pressure
Intubation, Endotracheal Tube Cuff Pressure
Recruiting
Hyperangulated vs Standard Videolaryngoscopy vs Direct Laryngoscopy for Double-Lumen Endobronchial Tube Intubation
Endobronchial Intubation, Double Lumen Tube Intubation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Timothy P Turkstra, M. Eng, MD principal investigator
University of Western Ontario, London Health Sciences Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing GlideScope Specific Stylet in people with Intubation, Endotracheal, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Oct 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Duration of Intubation (time frame: Timed intubation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2008.